Because of the highly heterogeneous molecular alterations of the disease, Perou et al. defined a classification based on gene expression patterns, dividing breast cancer into five molecular subtypes: luminal A, luminal B, HER2-enriched, basal-like, and normal-like, each characterized by a different clinical behavior [3,4]. This evidence concerns the gene ERBB2 and breast carcinoma.